STOCK TITAN

Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) will release its financial results for Q1 2022 on May 3, 2022, before market opening. A conference call will follow at 5:30 a.m. PT / 8:30 a.m. ET to discuss the results and business outlook. The event will be available for live audio streaming on the company’s investors' page. Nautilus is focused on advancing proteomics technology to enhance healthcare. For more information, visit www.nautilus.bio.

Positive
  • Anticipation of Q1 2022 financial results may build investor interest.
  • The company's focus on proteomics development positions it well for future growth.
Negative
  • None.

SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the first quarter 2022 before market open on Tuesday, May 3rd, 2022.

The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.nautilus.bio.

About Nautilus Biotechnology, Inc.

With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

Contacts

Investors:
InvestorRelations@nautilus.bio

Media:
Thermal for Nautilus Biotechnology
Kaustuva Das
Press@nautilus.bio


FAQ

When does Nautilus Biotechnology report its Q1 2022 financial results?

Nautilus Biotechnology will report its Q1 2022 financial results on May 3, 2022.

What time is the conference call for Nautilus Biotechnology's financial results?

The conference call will begin at 5:30 a.m. PT / 8:30 a.m. ET.

Where can I listen to the Nautilus Biotechnology conference call?

The conference call can be listened to live on the 'Investors' section of Nautilus' website.

What is the focus of Nautilus Biotechnology?

Nautilus Biotechnology focuses on developing a platform technology for quantifying the proteome.

Nautilus Biotechnolgy, Inc.

NASDAQ:NAUT

NAUT Rankings

NAUT Latest News

NAUT Stock Data

296.03M
125.56M
33.47%
50.18%
0.96%
Biotechnology
Laboratory Analytical Instruments
Link
United States of America
SEATTLE